Purchase Order 75N91018P00563

<p>The National Cancer Institute awarded a purchase order to Precision X Ray, Inc. valued at $18,515.00 on July 20, 2017. Work is performed at Bethesda, Maryland. The order is fixed price with economic price adjustment and completed on July 6, 2018.</p>

The National Cancer Institute (NCI) awarded a firm fixed-price purchase order to Precision X-Ray, Inc. for annual preventive maintenance services on one government-owned Precision X-Ray SMART+ system. The contract, valued at $249,999, covers maintenance services through March 31, 2027, with an award date of April 1, 2023. The work will be performed at the NCI's Bethesda, Maryland facility. This contract was not designated as a set-aside and represents a continuation of support for the...

<p>The National Cancer Institute awarded a purchase order to Precision X-Ray, Inc. for X-RAD 225CX dosimetry and ATP re-calibration, valued at $14,900, with an award date of July 30, 2019 and ultimate completion date of September 24, 2019. The order uses fixed-price pricing with economic price adjustment. Place of performance is Bethesda, Maryland.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. valued at $21,581.00 on August 28, 2018, with completion scheduled for September 28, 2018. Performance occurs at Bethesda, Maryland. The order is firm fixed price with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Oxford Instruments America, Inc. for $20,655.00 on August 28, 2017, with ultimate completion on September 13, 2018. Work is performed at Bethesda, Maryland. The order covers scientific equipment or related analytical instrumentation consistent with the vendor's product portfolio in electron microscopy systems, spectroscopy detectors, and associated maintenance services. Pricing is firm fixed price; no set-aside applies.</p>

This firm fixed price purchase order awarded by the National Institutes of Health's National Cancer Institute to Precision X-Ray, Inc. is for one Precision X-ray SmART+ small animal irradiator. The $715,250 contract will provide the requested commercially available precision irradiation equipment in support of radiation oncology research at the National Cancer Institute in Bethesda, Maryland. Key requirements included in the original solicitation were for an irradiator meeting specified...

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $12,768.84 on September 11, 2018, with completion scheduled for September 18, 2019. Pricing is fixed-price with economic price adjustment. Place of performance is Bethesda, Maryland. The source does not identify the specific items or services procured under this order.</p>

The National Cancer Institute issued a purchase order to Coherent Inc. on June 30, 2021, valued at $14,751.77, for maintenance agreement services with an ultimate completion date of July 24, 2022. The order represents a firm fixed-price acquisition to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of fund availability. Performance occurs in Bethesda, Maryland. No small business...

<p>The National Cancer Institute awarded a purchase order to Varian Medical Systems, Inc. on May 1, 2018, valued at $24,325.00 for fixed-price procurement with economic price adjustment adjustments, with ultimate completion April 30, 2019. No set-aside applied. Place of performance is Bethesda, Maryland. The source does not specify the particular goods or services procured under this order.</p>

<p>The National Cancer Institute awarded a purchase order to Biovision Technologies, Inc., a small business, for $23,860.40 on September 7, 2017, with an ultimate completion date of October 8, 2017. Place of performance is Bethesda, Maryland. The order calls for precision scientific imaging equipment or related optical/microscopy instrumentation. Pricing is firm fixed price.</p>